Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1724440 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL2411891 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL8841269 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL27301644 | 0.95 | — | — | |
| SCHEMBL32662715 | 0.94 | — | — | |
| Charcoal, Activated SCHEMBL30186803 | 0.94 | — | — | |
| SCHEMBL51586 | 0.94 | — | — | |
| SCHEMBL28462068 | 0.94 | — | — | |
| Bromide SCHEMBL4559985 | 0.89 | — | — | |
| Methane SCHEMBL10400168 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113145857-A | Copper-silver-tin ternary core-shell nano material and preparation method and application thereof | 广东工业大学 | 2021-07-23 | — | — | CN | claimed |
| EP-2500018-A1 | Preventing and/or Treating Cardiovascular Disease and/or Associated Heart Failure | PhilERA New Zealand Limited (NZ) | 2012-09-19 | — | — | EP | claimed |
| EP-1786363-A4 | MEDICAL DEVICES HAVING NANOPOROUS LAYERS AND METHODS FOR MAKING THE SAME | SETAGON INC (US) | 2008-04-23 | — | — | EP | claimed |
| JP-2008509742-A | — | — | 2008-04-03 | — | — | JP | claimed |
| EP-1786363-A2 | MEDICAL DEVICES HAVING NANOPOROUS LAYERS AND METHODS FOR MAKING THE SAME | Setagon, Inc. (US) | 2007-05-23 | — | — | EP | claimed |
| WO-2006020742-A2 | MEDICAL DEVICES HAVING NANOPOROUS LAYERS AND METHODS FOR MAKING THE SAME | SETAGON, INC. (US) | 2006-02-23 | — | — | WO | claimed |
| EP-1585506-A1 | METHODS AND COMPOSITIONS FOR WOUND MANAGEMENT | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2005-10-19 | — | — | EP | claimed |
| WO-2004056346-A1 | METHODS AND COMPOSITIONS FOR WOUND MANAGEMENT | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2004-07-08 | — | — | WO | claimed |
| JP-1244704-A | — | — | None | — | — | JP | disclosed |
| CN-113145857-A | Copper-silver-tin ternary core-shell nano material and preparation method and application thereof | 广东工业大学 | 2021-07-23 | — | — | CN | disclosed |
| CN-101646762-A | High surface area culture system with surface area enhancing substrate | CINV AG DE | 2010-02-10 | — | — | CN | disclosed |
| EP-1786363-A4 | MEDICAL DEVICES HAVING NANOPOROUS LAYERS AND METHODS FOR MAKING THE SAME | SETAGON INC (US) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007143433-A1 | NANOPOROUS STENTS WITH ENHANCED CELLULAR ADHESION AND REDUCED NEOINTIMAL FORMATION | SETAGON, INC. (US) | 2007-12-13 | — | — | WO | disclosed |
| EP-1786363-A2 | MEDICAL DEVICES HAVING NANOPOROUS LAYERS AND METHODS FOR MAKING THE SAME | Setagon, Inc. (US) | 2007-05-23 | — | — | EP | disclosed |
| CN-1688301-A | Dosage forms and related therapies | PROTEMIX CORP LTD (NZ) | 2005-10-26 | — | — | CN | disclosed |
| EP-0797650-A1 | PROCESS FOR THE ISOMERISATION OF A HYDROCARBONACEOUS FEEDSTOCK | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1997-10-01 | — | — | EP | disclosed |
| WO-1996018705-A1 | PROCESS FOR THE ISOMERISATION OF A HYDROCARBONACEOUS FEEDSTOCK | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 1996-06-20 | — | — | WO | disclosed |
| CN-1024665-C | process for preparing ring-substituted 2-amino-1, 2, 3, 4-tetrahydronaphthalenes | LILLY CO ELI (US) | 1994-05-25 | — | — | CN | disclosed |
| CN-1038644-A | Nuclear substituted 2-amino-1,2,3,4-tetralin class | LILLY CO ELI (US) | 1990-01-10 | — | — | CN | disclosed |
| JP-H01244704-A | BLACK PEARL AND ITS PRODUCTION | SHIMURA TADAMASA | 1989-09-29 | — | — | JP | disclosed |